CEO and President L Daniel Browne sold $215K of Revance Therapeutics, Inc.

Sold$215,005

$17.92Price

12,000Shares

−5%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Fri, Nov 25. Filed Fri, Nov 25, 4:32 PM ET, after the close. Not investment advice.